The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia

[1]  Cees G. M. Snoek,et al.  Variable Selection , 2019, Model-Based Clustering and Classification for Data Science.

[2]  M. Ferrari,et al.  Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study , 2018, The Lancet.

[3]  D. Dodick.  Migraine , 2018, The Lancet.

[4]  A. Hershey.  CGRP - The Next Frontier for Migraine. , 2017, The New England journal of medicine.

[5]  J. Gribben,et al.  Increased Vascular Permeability in the Bone Marrow Microenvironment Contributes to Disease Progression and Drug Response in Acute Myeloid Leukemia , 2017, Cancer cell.

[6]  R. Baron,et al.  ZFP521 regulates murine hematopoietic stem cell function and facilitates MLL-AF9 leukemogenesis in mouse and human cells. , 2017, Blood.

[7]  M. Caligiuri,et al.  Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia , 2017, Proceedings of the National Academy of Sciences.

[8]  N. Kannan,et al.  Cancer progression by reprogrammed BCAA metabolism in myeloid leukemia , 2017, Nature.

[9]  K. Caron,et al.  Lymphatic deletion of calcitonin receptor-like receptor exacerbates intestinal inflammation. , 2017, JCI insight.

[10]  Bob Löwenberg,et al.  Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. , 2017, Blood.

[11]  Claude Preudhomme,et al.  A 17-gene stemness score for rapid determination of risk in acute leukaemia , 2016, Nature.

[12]  Sébastien Lemieux,et al.  GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo. , 2016, Blood.

[13]  C. Grandi,et al.  Adrenomedullin in the growth modulation and differentiation of acute myeloid leukemia cells. , 2016, International journal of oncology.

[14]  G. Boucher,et al.  The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias , 2015, Nature Genetics.

[15]  E. Passegué,et al.  Normal and leukemic stem cell niches: insights and therapeutic opportunities. , 2015, Cell stem cell.

[16]  Alfredo Martínez,et al.  Adrenomedullin and tumour microenvironment , 2014, Journal of Translational Medicine.

[17]  S. Brain,et al.  Calcitonin gene-related peptide: physiology and pathophysiology. , 2014, Physiological reviews.

[18]  Ulrich Mansmann,et al.  Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis. , 2014, Blood.

[19]  J. Struck,et al.  Plasma adrenomedullin is associated with short-term mortality and vasopressor requirement in patients admitted with sepsis , 2014, Critical Care.

[20]  W. Hiddemann,et al.  Allogeneic transplantation versus chemotherapy as postremission therapy for acute myeloid leukemia: a prospective matched pairs analysis. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  D. Bertin,et al.  Adrenomedullin Blockade Suppresses Growth of Human Hormone–Independent Prostate Tumor Xenograft in Mice , 2013, Clinical Cancer Research.

[22]  Stephen Henderson,et al.  The G-Protein–Coupled Receptor CLR Is Upregulated in an Autocrine Loop with Adrenomedullin in Clear Cell Renal Cell Carcinoma and Associated with Poor Prognosis , 2013, Clinical Cancer Research.

[23]  Benjamin J. Raphael,et al.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.

[24]  M. Kersten,et al.  The hypoxia target adrenomedullin is aberrantly expressed in multiple myeloma and promotes angiogenesis , 2013, Leukemia.

[25]  N. Mochizuki,et al.  Vascular Endothelial Adrenomedullin-RAMP2 System Is Essential for Vascular Integrity and Organ Homeostasis , 2013, Circulation.

[26]  Joachim M. Buhmann,et al.  TMARKER: A free software toolkit for histopathological cell counting and staining estimation , 2013, Journal of pathology informatics.

[27]  Alfredo Martínez,et al.  Adrenomedullin as a Growth and Cell Fate Regulatory Factor for Adult Neural Stem Cells , 2012, Stem cells international.

[28]  M. Caligiuri,et al.  Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia. , 2011, Blood.

[29]  Yongzhang Luo,et al.  Tumor-Associated Macrophages Promote Angiogenesis and Melanoma Growth via Adrenomedullin in a Paracrine and Autocrine Manner , 2011, Clinical Cancer Research.

[30]  Jie-Ming Dong,et al.  Calcitonin gene-related peptide regulates the growth of epidermal stem cells in vitro , 2010, Peptides.

[31]  Christophe Dussert,et al.  Targeting adrenomedullin receptors with systemic delivery of neutralizing antibodies inhibits tumor angiogenesis and suppresses growth of human tumor xenografts in mice , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  M. Caligiuri,et al.  Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  Bas J. Wouters,et al.  Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling , 2009, Haematologica.

[34]  Y. Kurihara,et al.  Neuronal system-dependent facilitation of tumor angiogenesis and tumor growth by calcitonin gene-related peptide , 2008, Proceedings of the National Academy of Sciences.

[35]  C. Bloomfield,et al.  High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study. , 2008, Blood.

[36]  K. Döhner,et al.  High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics. , 2006, Blood.

[37]  W. Berdel,et al.  Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemia. , 2006, Haematologica.

[38]  H. Dressman,et al.  Molecular Profile and Partial Functional Analysis of Novel Endothelial Cell‐Derived Growth Factors that Regulate Hematopoiesis , 2006, Stem cells.

[39]  C. Bloomfield,et al.  BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  R. Verhaak,et al.  Prognostically useful gene-expression profiles in acute myeloid leukemia. , 2004, The New England journal of medicine.

[41]  M. Conconi,et al.  New immortalized human stromal cell lines enhancing in vitro expansion of cord blood hematopoietic stem cells. , 2004, International journal of molecular medicine.

[42]  Gurmeet Kaur,et al.  The effects of adrenomedullin overexpression in breast tumor cells. , 2002, Journal of the National Cancer Institute.

[43]  M. Oehler,et al.  Adrenomedullin promotes formation of xenografted endometrial tumors by stimulation of autocrine growth and angiogenesis , 2002, Oncogene.

[44]  N. Brünner,et al.  Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo. , 2002, The American journal of pathology.

[45]  C. Peschel,et al.  Regulation and function of the CGRP receptor complex in human granulopoiesis. , 2002, Experimental hematology.

[46]  M. Caligiuri,et al.  BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[47]  S. Rafii,et al.  Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. , 2000, The Journal of clinical investigation.

[48]  W. Berdel,et al.  Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. , 2000, Blood.

[49]  Jaleel A. Miyan,et al.  Neuropeptide control of bone marrow neutrophil production is mediated by both direct and indirect effects on CFU‐GM , 2000, British journal of haematology.

[50]  K. Kangawa,et al.  Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. , 1993, Biochemical and biophysical research communications.

[51]  H. Morris,et al.  Calcitonin gene-related peptide is a potent vasodilator , 1985, Nature.

[52]  E. Thiel,et al.  Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia , 2016, Leukemia.